How to establish brand preference among HCPs

Share this article:
How to establish brand preference among HCPs
Jeff Baker, CEO, Noble

In recent years, environmental factors have changed the way products are launched and managed throughout the lifecycle. The Sunshine & HITECH Acts, as well as the emergence of new device and formulation technologies, pose opportunities and risks to marketers looking to gain access, build loyalty and balance portfolios.

Biologic and specialty drugs have changed the prognosis for chronic and acute conditions. Beginning with the launch of initial blockbusters, “Biologics 1.0” became characterized by novel products with unique MOA's and clinical profiles. Due to stability and bioavailability of these compounds, injections (SC, IM or IV) became the most efficacious route in administering them.

As a result, prescribing decisions have become tied to both potential therapeutic benefits, and the total “Patient Experience” with a drug delivery device. For marketers, a number of strategies can augment this experience, increase adherence and establish brand preference with patients and HCPs.

As products come to market, patient and HCP choice increases. Adding value via an improved on-boarding experience with device training, can affect loyalty, market share, and patient confidence with new treatments. Physicians are likely to prescribe a brand that is easier to learn, causes fewer errors, has increased compliance and less of a patient drop-off.

For the marketer, this means improving your on-boarding process and patient experience via smart technologies. Marketers can do this by providing:

• More consistent and relevant training throughout the patient experience

• Personalized patient support and outreach programs

• Patient kits and training devices that build confidence

• Support for HCPs, with effective teaching tools that reduce in-office training times

• Long-term loyalty programs that engage patients and help them manage their treatment

Applying these principles and adopting a patient-centric approach is the first step in marketing a self-administered brand. Such principles have the potential to increase patient satisfaction. Brands that successfully balance patients, product and technology will remain a step ahead of the competition and top of mind for patients and HCPs.

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets

Private View: New ways to engage with customers

Private View: New ways to engage with customers

These healthcare social media campaigns successfully use emotion, altruism and the human desire to "brand" oneself to get customers engaged.